TrialThe New England journal of medicine2012
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
José Baselga et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,148 papers cite itlatest 60 shown
this paperpooled ittrialcites it